We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MS Drug Could Reduce Painful Adverse Effects of Cancer Treatment

News   Apr 30, 2018 | Original story from Rockefeller University Press

 
MS Drug Could Reduce Painful Adverse Effects of Cancer Treatment

Compared with control animals (left), the spinal cords of rats treated with bortezomib (center) contain increased numbers of activated astrocytes (green) that cause neuropathic pain. Bortezomib's effects are prevented by the multiple sclerosis drug fingolimod (right), which inhibits the sphingolipid metabolite receptor S1PR1. Credit: Stockstill et al., 2018

 
 
 

RELATED ARTICLES


‘You All Look Alike to Me’ is Hard-Wired in Us, Research Finds

News

Distinguishing other-race facial characteristics occurs in our earliest thought processes, UCR research finds.

READ MORE

Are the 'Viral' Agents of MS, ALS and Schizophrenia Buried in Our Genome?

News

Viruses hid themselves in your ancestors' DNA; now they're waking up.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE